scPharmaceuticals Inc. Reports Third Quarter 2024 Financial Results and Provides Business Update
scPharmaceuticals Inc. (SCPH)
Last scpharmaceuticals inc. earnings: 3/24 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
scpharmaceuticals.com
Company Research
Source: GlobeNewswire
Generated 3Q 2024 net FUROSCIX® revenue of $10.0 million, up 164% from Q3 2023 Received approval of label expansion to include New York Heart Association (NYHA) Class IV Patients Announced positive pharmacokinetic/pharmacodynamic (PK/PD) data on Autoinjector program Completed $125 million transformative financing in a combination of debt and equity that is anticipated to fund the Company through expected profitability Company to host investor conference call and webcast today, Wednesday, November 13th, at 4:30pm ET BURLINGTON, Mass., Nov. 13, 2024 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company committed to revolutionizing cardiorenal healthcare through patient-centric innovations, today announced financial results for the third quarter ended September 30, 2024, and provided a business update. Business Update For the third quarter ended September 30, 2024, scPharmaceuticals reports: Net FUROSCIX revenue of $10.0 million, representing a 24
Show less
Read more
Impact Snapshot
Event Time:
SCPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SCPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SCPH alerts
High impacting scPharmaceuticals Inc. news events
Weekly update
A roundup of the hottest topics
SCPH
News
- scPharmaceuticals Inc. (NASDAQ: SCPH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.MarketBeat
- scPharmaceuticals Inc. (NASDAQ: SCPH) had its price target lowered by analysts at Craig Hallum from $16.00 to $12.00. They now have a "buy" rating on the stock.MarketBeat
- scPharmaceuticals to Announce Third Quarter 2024 Financial Results on Wednesday, November 13, 2024GlobeNewswire
- scPharmaceuticals to Host Key Opinion Leader (KOL) Webinar on October 22, 2024GlobeNewswire
- scPharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceGlobeNewswire
SCPH
Earnings
- 11/13/24 - Miss
SCPH
Sec Filings
- 11/15/24 - Form SC
- 11/14/24 - Form SC
- 11/14/24 - Form SC
- SCPH's page on the SEC website